Edwards Lifesciences CVP, TAVR Daniel J. Lippis disposes of 619 common shares worth $54,168.69
Reuters2026/09/11 23:15- Edwards Lifesciences CVP, TAVR Daniel J. Lippis exercised employee stock options for 619 shares at $72.68 on Sep. 11, 2026.
- He sold 619 shares at $87.51 on the same day.
- Direct holdings totaled 40,033 shares following the transactions.
- He held 3,714 employee stock options after the exercise.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cantex Mine Development closes second tranche of private placement for $1.01 million proceeds
PVH CEO Stefan Larsson acquires USD 999,999 of common shares
The rebound of the yen may only be temporary, Morgan Stanley bets on arbitrage trades making a comeback, USD/JPY expected to rise to 163.
Morgan Stanley believes that the recent strengthening of the Japanese yen is mainly due to the unwinding of short-term arbitrage trades and market bets on Japanese capital repatriation, rather than any substantial improvement in fundamentals.

Control Empresarial de Capitales reports $24.63 million PBF Energy common share sale